Malaria in 2022: Increasing challenges, cautious optimism

Malaria cases and deaths remain unacceptably high and are resurgent in several settings, though recent developments inspire optimism. This includes the approval of the world’s first malaria vaccine and results from novel vaccine candidates and trials testing innovative combinatorial interventions.

Detalles Bibliográficos
Autores principales: Jagannathan, Prasanna, Kakuru, Abel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106727/
https://www.ncbi.nlm.nih.gov/pubmed/35562368
http://dx.doi.org/10.1038/s41467-022-30133-w
_version_ 1784708358078464000
author Jagannathan, Prasanna
Kakuru, Abel
author_facet Jagannathan, Prasanna
Kakuru, Abel
author_sort Jagannathan, Prasanna
collection PubMed
description Malaria cases and deaths remain unacceptably high and are resurgent in several settings, though recent developments inspire optimism. This includes the approval of the world’s first malaria vaccine and results from novel vaccine candidates and trials testing innovative combinatorial interventions.
format Online
Article
Text
id pubmed-9106727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91067272022-05-15 Malaria in 2022: Increasing challenges, cautious optimism Jagannathan, Prasanna Kakuru, Abel Nat Commun Comment Malaria cases and deaths remain unacceptably high and are resurgent in several settings, though recent developments inspire optimism. This includes the approval of the world’s first malaria vaccine and results from novel vaccine candidates and trials testing innovative combinatorial interventions. Nature Publishing Group UK 2022-05-13 /pmc/articles/PMC9106727/ /pubmed/35562368 http://dx.doi.org/10.1038/s41467-022-30133-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Jagannathan, Prasanna
Kakuru, Abel
Malaria in 2022: Increasing challenges, cautious optimism
title Malaria in 2022: Increasing challenges, cautious optimism
title_full Malaria in 2022: Increasing challenges, cautious optimism
title_fullStr Malaria in 2022: Increasing challenges, cautious optimism
title_full_unstemmed Malaria in 2022: Increasing challenges, cautious optimism
title_short Malaria in 2022: Increasing challenges, cautious optimism
title_sort malaria in 2022: increasing challenges, cautious optimism
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106727/
https://www.ncbi.nlm.nih.gov/pubmed/35562368
http://dx.doi.org/10.1038/s41467-022-30133-w
work_keys_str_mv AT jagannathanprasanna malariain2022increasingchallengescautiousoptimism
AT kakuruabel malariain2022increasingchallengescautiousoptimism

Ejemplares similares